Skip to content
GLP-1 Desk
Menu

Head-to-head dispatch

Telos Rx vs Virta Health

Two GLP-1 providers, one scorecard. Both are graded on the same six Desk Score dimensions — here is how they stack up, and which one fits you.

Dispatch #19Desk pick
Telos Rx

The broadest published catalog in the ranking — compounded GLP-1s plus oral and microdosed tirzepatide, PT-141, intranasal NAD+, and recovery peptides — all compounded and not FDA-approved.

$99/mo (injectable, month-to-month; the $49 headline is only the FIRST month of the 12-month prepaid ORAL plan, which renews at $129/mo billed every 48 weeks) sema · $139/mo injectable · $129/mo oral · $116/mo microdosed (microdosing is tirzepatide, not semaglutide) tirz

Marked down on: Everything is compounded and not FDA-approved — including all peptides and the NAD+ spray

vs
Dispatch #431
Virta Health

Virta Health is a nutrition-first virtual program for diabetes reversal and sustainable weight loss, distributed through employers and health plans at no cost to members.

Marked down on: Primarily a nutrition program; GLP-1s are a secondary track

Telos Rx takes this head-to-head with the higher Desk Score, 85/100 (B) against 50/100 (C) for Virta Health. Virta Health still holds its ground where its strengths line up with yours.

Desk Score, dimension by dimension

Same six measured dimensions for both. The red flag marks the stronger side. See the methodology.

Telos Rx

85/100

B

Overall

Virta Health

50/100

C

Price transparency

74
30

State access

62
24

Molecule range

98
51

Onboarding speed

84
66

Support responsiveness

76
87

Licensing & trust

88
80

The spec sheet

FieldTelos RxVirta Health
Semaglutide$99/mo (injectable, month-to-month; the $49 headline is only the FIRST month of the 12-month prepaid ORAL plan, which renews at $129/mo billed every 48 weeks)Not listed on Virta Health's site (checked July 26, 2026)
Tirzepatide$139/mo injectable · $129/mo oral · $116/mo microdosed (microdosing is tirzepatide, not semaglutide)Not listed on Virta Health's site (checked July 26, 2026)
CoverageNot listed on Telos Rx's siteNot listed on Virta Health's site (checked July 26, 2026)
Brand-nameCompounded onlyCompounded only
Oral optionYesYes
Best forPatients who want GLP-1 care alongside peptides, NAD+, and sexual-health options on one certified platform, with a needle-free oral or microdosed route.Plan members wanting nutrition-first care with optional monitored GLP-1 use.
Desk Score85/100B50/100C

The verdict

Desk pick — Telos Rx

Telos Rx takes this head-to-head with the higher Desk Score, 85/100 (B) against 50/100 (C) for Virta Health. Virta Health still holds its ground where its strengths line up with yours.

Choose Telos Rx if…

Patients who want GLP-1 care alongside peptides, NAD+, and sexual-health options on one certified platform, with a needle-free oral or microdosed route.

$99/mo (injectable, month-to-month; the $49 headline is only the FIRST month of the 12-month prepaid ORAL plan, which renews at $129/mo billed every 48 weeks) sema · $139/mo injectable · $129/mo oral · $116/mo microdosed (microdosing is tirzepatide, not semaglutide) tirz

Choose Virta Health if…

Plan members wanting nutrition-first care with optional monitored GLP-1 use.

Assume any provider we list may compensate us — we may earn a referral commission at no extra cost to you, and what we file on a provider reads the same either way. Read full breakdowns: Telos Rx · Virta Health.

Also here

CoreAge Rx tops every dispatch at 94/100

Whichever of these two you lean toward, the Desk's #1-rated provider outscores them both. The Desk's top dispatch: one price at every dose, both molecules, all 50 states — but the $99 and $149 figures are 12-month plans paid up front, not a monthly bill.

More head-to-heads

Or see the full comparison hub and the complete ranking.

Pricing and verification reflect each provider's public disclosures at last scoring; the Desk Score is our editorial judgment per the methodology. Prices change — confirm on each provider's own site. Not medical advice; see our disclosure.